Adi Kaushal is Director and Technology Head for Bioavailability Enhancement at Lonza and is based in Bend, Oregon, USA. He has over 20 years of formulation experience and has been with Lonza (previously Bend Research) since 2010.

Adi is responsible for overall BAE technology strategy and progression of customer programs from feasibility to commercialization. Adi’s group of over 50 experienced scientists and engineers are engaged in bringing new BAE technologies to product development, customer centric advancements, and continuous improvement of Lonza internal systems. Adi also supports collaboration with internal R&D within the Lonza Advanced Synthesis Platform.

Adi holds a PhD in Pharmaceutical Technology and is an inventor on four patents and has co-authored over 25 peer-reviewed articles on bioavailability enhancement, oral solid dosage and modified release in international journals.

Ask Adi about how Lonza can help advance your molecule- -

• Bioavailability enhancement (BAE) • Amorphous solid dispersions (ASD) • Spray dried dispersions (SDD) • Hot melt extrusion (HME) • Nanomilling • Micronization - • Solid form selection • Physiologically based biopharmaceutics modeling (PBBM) - • Material sparing approach • Right first time • Early phase clinical manufacturing (EPCM) • Commercial ready formulation • Late stage and commercial manufacturing - • Modified release • Pediatric dosage forms